ClinicalTrials.Veeva

Menu

The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta

M

Minia University

Status

Unknown

Conditions

Placenta Previa Accreta
Placenta Previa

Treatments

Procedure: The cervix as a natural tamponade (cervical inversion)

Study type

Interventional

Funder types

Other

Identifiers

NCT02590484
MUH14367

Details and patient eligibility

About

Placenta previa and placenta accrete carry significant maternal and fetal morbidity and mortality. Several techniques have been described in the literature for controlling massive bleeding associated with placenta previa cesarean sections. The aim of this study is to evaluate the efficacy and safety of the use of the cervix as a natural tamponade in controlling postpartum hemorrhage caused by placenta previa and placenta previa accreta.

Full description

Background: Placenta previa and placenta accrete carry significant maternal and fetal morbidity and mortality. The maternal mortality in women with placenta accreta may reach as high as 7-10%. Several techniques have been described in the literature for controlling massive bleeding associated with placenta previa cesarean sections, including uterine packing with gauze, balloon tamponades, the B-Lynch suture, insertion of parallel vertical compression sutures, a square suturing technique and embolization or ligation of the uterine and internal iliac arteries, but there is a wide variation in the success rate of these maneuvers. In a case report, Dawlatly et al. (2007) described a simple technique of suturing an inverted lip of the cervix over the bleeding placental bed that was successful in controlling the bleeding, saving the patient's life, and preserving her uterus.

The objective of this trial is to evaluate the safety and efficacy of the use of this Dawlatly stitch as a natural tamponade for controlling postpartum haemorrhage in cases of placenta previa and/ or placenta previa accreta.

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. All participating women had one or more previous cesarean deliveries.
  2. were diagnosed with placenta previa and/ or placenta previa accreta by ultrasound. When the ultrasound result was not conclusive for placenta accreta, MRI was performed.
  3. All participating women desired to preserve their fertility
  4. Patients with focal (partial) placenta previa accreta/ placenta previa.

Exclusion criteria

  1. placenta percreta.
  2. diffuse placenta accreta or increta.
  3. uncontrollable postpartum hemorrhage.

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed R Abdelraheim, MD, MRCOG

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems